|Application ||WB, IHC-P, IF|
|Calculated MW||H=26;M=25;Rat=25 KDa|
|Antigen Region||206-234 aa|
|Other Names||MESDC2; KIAA0081; MESD; LDLR chaperone MESD; Mesoderm development candidate 2; Mesoderm development protein; Renal carcinoma antigen NY-REN-61|
|Target/Specificity||This MESDC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 206-234 amino acids from the C-terminal region of human MESDC2.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||MESDC2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Chaperone specifically assisting the folding of beta- propeller/EGF modules within the family of low-density lipoprotein receptors (LDLRs). Acts as a modulator of the Wnt pathway through chaperoning the coreceptors of the canonical Wnt pathway, LRP5 and LRP6, to the plasma membrane. Essential for specification of embryonic polarity and mesoderm induction.|
|Cellular Location||Endoplasmic reticulum|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Chaperone specifically assisting the folding of beta-propeller/EGF modules within the family of low-density lipoprotein receptors (LDLRs). Acts as a modulator of the Wnt pathway through chaperoning the coreceptors of the canonical Wnt pathway, LRP5 and LRP6, to the plasma membrane. Essential for specification of embryonic polarity and mesoderm induction.
Murrills, R.J., et al. J. Cell. Biochem. 108(5):1066-1075(2009)
Li, Y., et al. FEBS Lett. 580(22):5423-5428(2006)
Veltman, I.M., et al. Hum. Mol. Genet. 14(14):1955-1963(2005)
Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)
Hsieh, J.C., et al. Cell 112(3):355-367(2003)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.